e-learning
resources
Amsterdam 2015
Monday, 28.09.2015
To treat or not to treat? Sleep-disordered breathing II
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
Upper airway stimulation for obstructive sleep apnea: Quality of life outcome after 30 months of follow-up
Johan Verbraecken (Edegem (Antwerp), Belgium), Johan Verbraecken, Winfried Randerath, On Behalf of the STAR Trial Investigators
Source:
International Congress 2015 – To treat or not to treat? Sleep-disordered breathing II
Session:
To treat or not to treat? Sleep-disordered breathing II
Session type:
Thematic Poster Session
Number:
2427
Disease area:
Sleep and breathing disorders
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
Johan Verbraecken (Edegem (Antwerp), Belgium), Johan Verbraecken, Winfried Randerath, On Behalf of the STAR Trial Investigators. Upper airway stimulation for obstructive sleep apnea: Quality of life outcome after 30 months of follow-up. Eur Respir J 2015; 46: Suppl. 59, 2427
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
The Relationship Between Functional Status and Fatigue After COVID-19 Infection
Observational cohort study of pulmonary exacerbations in alpha-1 antitrypsin deficiency
ERS clinical practice guidelines on treatment of sarcoidosis
Related content which might interest you:
Performance of utility instruments in evaluating response to CPAP in patients with obstructive sleep apnea
Source: International Congress 2014 – The technical and diagnostic agenda in OSA
Year: 2014
Voice analysis in patients with obstructive sleep apnea syndrome
Source: International Congress 2015 – Paediatric and adult sleep-disordered breathing: from inflammation to treatment and telemedicine
Year: 2015
The efficacy of a chinstrap in the treatment of obstructive sleep apnea
Source: Annual Congress 2013 –Twist in the tale: treating sleep disordered breathing - new technologies, new techniques
Year: 2013
Upper airway stimulation for obstructive sleep apnoea: Patient reported outcomes after 48 months of follow-up
Source: International Congress 2016 – Non-CPAP in obstructive and central sleep apnoea and obesity hypoventilation syndrome
Year: 2016
Prospective echocardiographic study of right and left cardiac function during sleep in obstructive sleep apnea syndrome: Assessment at 1 month and 6 months of treatment with CPAP
Source: International Congress 2014 – Sleep disordered breathing 2
Year: 2014
Impact of septoplasty in the severity and treatment of sleep apnea
Source: Annual Congress 2013 –Have we advanced in the treatment of sleep disordered breathing?
Year: 2013
Quality of life measurements are valid indicators of obstructive sleep apnea
Source: Eur Respir J 2002; 20: Suppl. 38, 452s
Year: 2002
Development of the Manchester sleep symptoms index in COPD
Source: International Congress 2014 – The technical and diagnostic agenda in OSA
Year: 2014
Short term effects of neck-based treatment and monitoring device for positional obstructive sleep apnea
Source: International Congress 2015 – To treat or not to treat? Sleep-disordered breathing II
Year: 2015
Single center experience of selective upper airway stimulation in 45 patients with obstructive sleep apnea
Source: International Congress 2016 – Non-CPAP in obstructive and central sleep apnoea and obesity hypoventilation syndrome
Year: 2016
Quality of life impairment in patients with obstructive sleep apnea
Source: Virtual Congress 2021 – Pathophysiology and clinical consequences of obstructive sleep apnoea
Year: 2021
Quality of life in patients at first time visit for sleep disorders of breathing at a sleep centre
Source: Annual Congress 2013 –Have we advanced in the treatment of sleep disordered breathing?
Year: 2013
CPAP treatment response in obstructive sleep apnea using the AERScore predictor
Source: International Congress 2015 – Measuring sleep-disordered breathing in children and adults II: questionnaires, epidemiology and sleep studies
Year: 2015
Smoking status, clinical presentation and outcomes in obstructive sleep apnoea
Source: International Congress 2014 – The story continues: impact of OSA on cardiometabolic parameters
Year: 2014
The Epworth sleepiness scale 23 years after: Is daytime sleepiness still a valid screening tool for sleep apnea
Source: International Congress 2014 – Sleep disordered breathing 4
Year: 2014
Correlation between sleep parameters, physical activity and quality of life in somnolent moderate to severe obstructive sleep apnea adult patients
Source: Annual Congress 2013 –Have we advanced in the treatment of sleep disordered breathing?
Year: 2013
Impact of smoking on the severity of sleep apnea syndrome
Source: International Congress 2014 – Evaluating sleep disordered breathing in children and adults
Year: 2014
Validity of Berlin questionnaire for obstructive sleep apnea in a sleep clinic population
Source: Annual Congress 2013 –Ask, see and do: old and new technology in sleep disordered breathing
Year: 2013
Prevalence of sleep apnoea and its associated impact on quality of life in a primary care COPD population
Source: International Congress 2016 – Managing multimorbidity and lifestyle change in primary care
Year: 2016
Quality of life among sleep apnea patients before and after treatment with continuous positive airway pressure (CPAP) compared to controls from the general population
Source: Annual Congress 2013 –Have we advanced in the treatment of sleep disordered breathing?
Year: 2013
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept